Employees: 11-50
Total raised: $16M
Founded date: 2015
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.07.2022 | Series B | $16M | - |
Mentions in press and media 4
| Date | Title | Description |
| 19.07.2022 | Stimdia Medical raises $16M for neurostim to get people off ventilators | Stimdia Medical announced recently that it completed the initial closing of a $16 million tranche of its Series B financing round. Solas Bioventures led the financing round, while new strategic partners and existing investors Draper Triangl... |
| 14.07.2022 | Stimdia Medical Raises USD16M in First Close of Series B Equity Financing | Stimdia Medical, a Minneapolis, MN-based developer of neurostimulation technology, raised USD16M in funding. The round, which represents the first tranche of a Series B offering totaling $30M, was led by Solas BioVentures with participation... |
| 18.03.2021 | CORRECTING and REPLACING Stimdia Medical Receives FDA Breakthrough Device Designation for the pdSTIM™ System Designed to Facilitate Weaning Patients from Mechanical Ventilation | MINNEAPOLIS--(BUSINESS WIRE)--Mar 18, 2021-- Please replace the release with the following corrected version due to revisions. The updated release reads: STIMDIA MEDICAL RECEIVES FDA BREAKTHROUGH DEVICE DESIGNATION FOR THE PDSTIM™ SYSTEM DE... |
| 18.03.2021 | Stimdia Medical Receives FDA Breakthrough Device Designation for the pdSTIM™ System Designed to Facilitate Weaning Patients from Mechanical Ventilation | MINNEAPOLIS--(BUSINESS WIRE)--Mar 18, 2021-- Stimdia Medical, Inc., an emerging leader in the development of technology to reduce weaning time for patients on mechanical ventilation, today announced the company’s pdSTIM™ System has received... |